MINNEAPOLIS (CN) - More than 90 percent of patients diagnosed with nephrogenic systemic fibrosis, a progressive, incurable and potentially deadly disease, received injections of General Electric's ...

March 7: This post has been updated to incorporate a response from GE. In 1994, a scientist studying her company's new medical imaging dye reached troubling findings. Her boss, she recalls, told her ...

General Electric is in a liability fight over a rare and sometimes fatal disease that has been linked to a dye used for MRI scans, with a preponderance of cases involving a GE product called Omniscan.

The OmniScan TM X4 multitechnology series is a portable, effective solution that increases test productivity and confidence through speed and versatility. Its advanced phased array capabilities, ...